Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Sendecki

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Medical Devices|March 2, 2021
Intraoperative OCT microscopy in 3DAdam Wylęgała, Adam Sendecki, Edward Wylęgała
Genes|September 28, 2023
Polygenic Risk Score and Rare Variant Burden Identified by Targeted Sequencing in a Group of Patients with Pigment Epithelial Detachment in Age-Related Macular DegenerationAnna Wąsowska, Adam Sendecki, Anna Boguszewska-Chachulska, et al.
Journal of Clinical Medicine|January 8, 2023
Polygenic Risk Score Impact on Susceptibility to Age-Related Macular Degeneration in Polish PatientsAnna Wąsowska, Sławomir Teper, Ewa Matczyńska, et al.
Acta Ophthalmologica|May 18, 2024
A deep learning approach to explore the association of age-related macular degeneration polygenic risk score with retinal optical coherence tomography: A preliminary studyAdam Sendecki, Daniel Ledwoń, Julia Nycz, et al.
Biomedicines|September 28, 2024
Fundus Image Deep Learning Study to Explore the Association of Retinal Morphology with Age-Related Macular Degeneration Polygenic Risk ScoreAdam Sendecki, Daniel Ledwoń, Aleksandra Tuszy, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Association of Genetic Risk for Age-Related Macular Degeneration with Morphological Features of the Retinal Microvascular NetworkAdam Sendecki, Daniel Ledwoń, Aleksandra Tuszy, et al.
Acta Ophthalmologica|November 17, 2025
Long-term outcomes of nationwide coordinated neovascular AMD treatment: A study based on Polish national registrySławomir Teper, Daniel Ledwoń, Adam Sendecki, et al.
Journal of Clinical Medicine|October 16, 2025
Twelve-Month Outcomes of Anti-VEGF Therapy for nAMD with Brolucizumab, Aflibercept, and Ranibizumab in the Polish National Registry: A Multicenter Database StudySławomir Teper, Daniel Ledwoń, Patrycja Romaniszyn-Kania, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Medical Devices|March 2, 2021
Intraoperative OCT microscopy in 3DAdam Wylęgała, Adam Sendecki, Edward Wylęgała
Genes|September 28, 2023
Polygenic Risk Score and Rare Variant Burden Identified by Targeted Sequencing in a Group of Patients with Pigment Epithelial Detachment in Age-Related Macular DegenerationAnna Wąsowska, Adam Sendecki, Anna Boguszewska-Chachulska, et al.
Journal of Clinical Medicine|January 8, 2023
Polygenic Risk Score Impact on Susceptibility to Age-Related Macular Degeneration in Polish PatientsAnna Wąsowska, Sławomir Teper, Ewa Matczyńska, et al.
Acta Ophthalmologica|May 18, 2024
A deep learning approach to explore the association of age-related macular degeneration polygenic risk score with retinal optical coherence tomography: A preliminary studyAdam Sendecki, Daniel Ledwoń, Julia Nycz, et al.
Biomedicines|September 28, 2024
Fundus Image Deep Learning Study to Explore the Association of Retinal Morphology with Age-Related Macular Degeneration Polygenic Risk ScoreAdam Sendecki, Daniel Ledwoń, Aleksandra Tuszy, et al.
Diagnostics (Basel, Switzerland)|April 13, 2024
Association of Genetic Risk for Age-Related Macular Degeneration with Morphological Features of the Retinal Microvascular NetworkAdam Sendecki, Daniel Ledwoń, Aleksandra Tuszy, et al.
Acta Ophthalmologica|November 17, 2025
Long-term outcomes of nationwide coordinated neovascular AMD treatment: A study based on Polish national registrySławomir Teper, Daniel Ledwoń, Adam Sendecki, et al.
Journal of Clinical Medicine|October 16, 2025
Twelve-Month Outcomes of Anti-VEGF Therapy for nAMD with Brolucizumab, Aflibercept, and Ranibizumab in the Polish National Registry: A Multicenter Database StudySławomir Teper, Daniel Ledwoń, Patrycja Romaniszyn-Kania, et al.
Pageof 1